Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) sits in the top decile of US sponsors by registered trial count (#116 of 15,742 sponsors by registered trial count).

305 total trials 24 currently recruiting 252 completed early-phase tilt top decile by trial count

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD): 305 sponsored US clinical trials, 24 recruiting.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) sponsors 305 registered US clinical trials on ClinicalTrials.gov, 24 of them currently recruiting, and 252 completed. 35 of these trials are in Phase 3-4 (later-stage) and 89 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Pregnancy, with 8 trials.

Top-decile sponsor footprint

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) ranks in the top decile of sponsors by registered trial count (#116 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 66/100

252 of 279 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

305 total, page 4 of 7

COMPLETED Phase 1

Metabolism of Nicotine and Cotinine in Pregnant African-American Women

NCT00341640

COMPLETED

Effect of Experience on Driving Performance in New Teenage Drivers

NCT00340561

COMPLETED Phase 1

Family Management of Childhood Diabetes Study

NCT00340938

COMPLETED Phase 1

Anthrax Vaccine Clinical Trials

NCT00114621

COMPLETED NA

Comprehensive Elementary School Risk Prevention

NCT00099385

COMPLETED Phase 2

Yoga for Kyphosis Trial

NCT00781729

COMPLETED

Event Related Potentials in Infants and Adults

NCT00088712

COMPLETED Phase 3

Medical Treatment of Endometriosis-Associated Pelvic Pain

NCT00229996

COMPLETED

Colpocleisis for Advanced Pelvic Organ Prolapse

NCT00271037

COMPLETED Phase 2

Shoulder, or Elbow, or Wrist: What Should we Train First After a Stroke?

NCT00453843

COMPLETED Phase 1

Smoking Cessation Aid for Young Smokers

NCT00340483

COMPLETED

Evaluation and Treatment of Patients With Connective Tissue Disease

NCT00076830

COMPLETED Phase 1

A Pharmacokinetic Study of Dexmedetomine in Infants

NCT00459082

COMPLETED Phase 1

Inspiratory Muscle Training in Ventilator Dependent Patients

NCT00419458

COMPLETED Phase 3

Trial of Three Neonatal Antiretroviral Regimens for Prevention of Intrapartum HIV Transmission

NCT00099359

COMPLETED Phase 2

Sedation Management in Pediatric Patients Supported on Mechanical Ventilation

NCT00142766

COMPLETED

Interviewing Children About Past Events: Evaluating the NICHD Interview Protocol

NCT00343018

COMPLETED

Eating Behavior in Children

NCT00320177

COMPLETED Phase 2

Managing Recurrent Abdominal Pain

NCT00494260

COMPLETED Phase 1

E. Coli for Prevention of Catheter UTI in SCI Patients

NCT00458471

COMPLETED

The Role of Susceptibility to Thrombosis in the Pseudotumor Cerebri of Nephropathic Cystinosis: A Case-Control Study

NCT00071903

COMPLETED

Studying Fetal Breathing Patterns

NCT00066976

COMPLETED Phase 3

Michigan Driver Education Study

NCT00340470

COMPLETED Phase 2

Steppin' Up: Positive Youth Development Program

NCT00341224

COMPLETED

Environmental and Behavioral Risk Factors for Childhood Drowning

NCT00341289

COMPLETED Phase 4

Quick Start Approach to Birth Control Pills

NCT00068848

COMPLETED

Infant s Examination and Manipulation of Objects

NCT00053469

COMPLETED

Management of Type 1 Diabetes Among Adolescents

NCT00340639

COMPLETED

Intrauterine Environment in Polycystic Ovary Syndrome (PCOS) Probands

NCT00364949

COMPLETED NA

Ultrasound-indicated Cerclage to Prevent Premature Birth in High-risk Women

NCT00059683

COMPLETED Phase 1

HIV Prevention in Haitian American Adolescents

NCT00494273

COMPLETED Phase 4

The Role of 5-alpha Reductase in Mediating Testosterone Actions

NCT00493987

COMPLETED Phase 3

Treatment of Infertility in Women With Polycystic Ovary Syndrome

NCT00068861

COMPLETED

Study of Inborn Errors of Cholesterol Synthesis and Related Disorders

NCT00046202

COMPLETED Phase 3

Community Trial of Newborn Skin and Umbilical Cord Cleansing on Neonatal Mortality in Nepal

NCT00109616

COMPLETED Phase 1

Single Dose Pharmacokinetic and Pharmacodynamic Evaluation of Three Different Doses of Zolpidem in Children

NCT00494468

COMPLETED

Diagnostic Performance of Screening Tests for Cushing s Syndrome

NCT00361777

COMPLETED Phase 2

Treatment of Uterine Fibroids With CDB-2914, an Experimental Selective Progesterone Receptor Antagonist

NCT00044876

COMPLETED Phase 1

Diabetes Management Personal Trainer

NCT00340093

COMPLETED

Dyadic Interactions in Depressed and Non-Depressed Mothers and Their Infants

NCT00044174

COMPLETED NA

Therapy for Reading Problems in Adults After Brain Injury

NCT00064805

COMPLETED

Study of Adrenal Gland Tumors

NCT00005927

COMPLETED NA

Treatment of Self-Injurious Behavior in Individuals With Prader-Willi Syndrome

NCT00065923

COMPLETED

Interventions to Decrease the Risk of Mother-to-Child Transmission of HIV in India

NCT00341796

COMPLETED

Human MATER and Idiopathic Infertility

NCT00361816

COMPLETED Phase 1

Comparison of Blood Levels of Two Formulations of the Selective Hormone Receptor Modulator CDB-2914

NCT00041899

COMPLETED Phase 3

Colpopexy and Urinary Reduction Efforts (CARE) Protocol

NCT00065845

COMPLETED NA

Middle Ear Disease Before Age 3, Treatment With Ear Tubes, and Literacy and Attentional Abilities at Ages 9 to 11

NCT00365092

COMPLETED Phase 2

Parent-Youth Teamwork in Pediatric Asthma Management

NCT00166582

COMPLETED Phase 3

Supplemental Calcium in Overweight People

NCT00030238

← Previous Page 4 of 7 Next →

Phase Distribution

PhaseTrial count
Phase 1 40
Phase 2 49
Phase 3 23
Phase 4 12

What is open in the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) pipeline

24 recruiting of 305 indexed (8% open); 252 completed (83%).

Phase mix: 35 late (III/IV) vs 89 early (I/II) (early-phase heavy).

Top condition: Pregnancy (8 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD): open-pipeline peers nationwide

Peers matched on 305 registered trials and 8% open enrollment, not the therapeutic-area sidebar.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 02004006008001,000 0%5%10%15% Total trials Recruiting share Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)CelgeneAllerganKaiser PermanenteUniversity of ArkansasBoston Scientific CorporationNovo Nordisk A/SHoffmann-La RocheUnited Therapeutics
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 305 trials (± recruiting share)

Sponsors near 8% open enrollment (± trial volume)

What to do with this Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) page

305 registered trials is a research-attention snapshot, not an endorsement of Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) or any single study.

  • 24 of Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)'s trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Pregnancy is the condition Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Pregnancy trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) pipeline card: 305 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.